Scilex Holding Company

Last updated September 27, 2026

Organization details

Legal name
Scilex Holding Company
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
SCLX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001820190

Board of directors

Chief executives

Henry Ji · CEO and President
Dates unknown

Board connections

4 of this board's directors also sit on 8 other boards.

Network of Scilex Holding Company's board connections Aardvark Therapeutics Inc. Aardvark Therapeutics... AnaptysBio Inc. AnaptysBio Inc. Fate Therapeutics Inc. Fate Therapeutics Inc. Healthpeak Properties Inc. Healthpeak Properties... Jazz Pharmaceuticals plc Jazz Pharmaceuticals p... Silence Therapeutics Plc American Depository Share Silence Therapeutics P... TherapeuticsMD Inc. TherapeuticsMD Inc. United Therapeutics Corporation United Therapeutics Co... David Lemus David Lemus Laura Hamill Laura Hamill Tien-Li Lee Tien-Li Lee Tommy G. Thompson Tommy G. Thompson Scilex Holding Company
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$12,806,953
3 sales by 1 insider
Date Insider Transaction Shares Price Value
Jul 3, 2026 SCLX Stock Acquisition JV LLC 10% owner Other −500,000 — —
Dec 30, 2025 Scilex Holding Co 10% owner Open-market sale −9,657,300 $0.54 $5,214,942
Dec 29, 2025 Scilex Holding Co 10% owner Open-market sale −7,310,984 $0.66 $4,825,249
Dec 26, 2025 Scilex Holding Co 10% owner Open-market sale −3,689,016 $0.75 $2,766,762
Jan 21, 2025 SCLX Stock Acquisition JV LLC 10% owner Other −3,250,000 — —
Jan 16, 2025 SCLX Stock Acquisition JV LLC 10% owner Other −779,371 — —
Jan 2, 2025 SCLX Stock Acquisition JV LLC 10% owner Other −5,000,000 — —
Dec 18, 2024 Jaisim Shah Director, Officer (See Remarks) Open-market purchase +30,000 $0.46 $13,800
Oct 31, 2024 Henry Ji Director, Officer (Executive Chairperson) Open-market purchase +8,888 $0.94 $8,355
Oct 29, 2024 Jaisim Shah Director, Officer (See Remarks) Open-market purchase +32,000 $0.99 $31,680
Oct 18, 2024 Dorman Followwill Director Open-market purchase +1,000 $0.99 $990
Oct 18, 2024 Jay Chun Director Open-market purchase +5,000 $0.95 $4,750
Oct 17, 2024 Yue Alexander Wu Director Open-market purchase +20,000 $0.95 $19,000
Oct 17, 2024 David Lemus Director Open-market purchase +2,000 $0.90 $1,800
Oct 17, 2024 Henry Ji Director, Officer (Executive Chairperson) Open-market purchase +10,000 $0.97 $9,700

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.